Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient
Real World Status of Palliative Care for Pancreatic Cancer Patients in China-a National Multi-center Cross-sectional Survey
1 other identifier
observational
450
1 country
1
Brief Summary
It is a real-world observational cross-sectional follow-up study on clinical palliative care for pancreatic cancer patients in China. It is evaluated by an online questionnaire sent to the doctors from the General Surgery Department in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 3, 2023
CompletedFirst Posted
Study publicly available on registry
October 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedOctober 19, 2023
October 1, 2023
1 year
October 3, 2023
October 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Descriptions and scores of real status of hospice care in different hospitals
The primary outcome is objective standards and subjective scores of current status of palliative care to qutify the development of palliative care of different hospitals. The score is evaluated by a follow-up questionnaire. The maximum and minimum score is 10 and 0, respectively.
1 month
Study Arms (1)
Pancreatic cancer patients
Interventions
Eligibility Criteria
The doctors of the Department of General Surgery in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland
You may qualify if:
- Doctors from the General Surgery Department in Chinese public tertiary teaching hospitals and public primary care units
- Approval to participate
- Participants with a valid and complete questionnaire evaluated by 2 experienced surgeons
You may not qualify if:
- Refusal to participate
- Participants with an invalid or incomplete questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Qiaofei Liu
Department of General Surgery, Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department director assistant, clinical chief professor
Study Record Dates
First Submitted
October 3, 2023
First Posted
October 19, 2023
Study Start
September 1, 2023
Primary Completion
September 1, 2024
Study Completion
September 1, 2025
Last Updated
October 19, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share